In this episode of The UroOnc Minute, Carissa Chu, MD, discusses the prevalence, biology, prognostic significance, and emerging molecular targets of variant histologies in bladder cancer.
Carissa Chu, MD
Advertisement
Articles by Carissa Chu, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Ac-225 rosopatamab tetraxetan shows promising activity in Lu-PSMA–pretreated mCRPC
2
Gopa Iyer, MD, highlights data on anti-Nectin-4 ADC for metastatic urothelial carcinoma
3
FDA updates in urology: June 2026
4
Published VAPOR 2 data evaluate water vapor ablation for localized prostate cancer
5